Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by gijo333on Feb 17, 2017 8:58am
206 Views
Post# 25860045

RE:RE:We need news!

RE:RE:We need news!I'm sorry you think I'm bashing. Its all about risk reward. I have stood by and watched my  shares loose more than 50% value over the last few months. I'm not bashing, I'm expressing my frustration with Groome's management. To make matters worse he walks off the job. And if that was not bad enough the BOD replaces Groome with Kym, the same guy who has dumped over a million shares since last October. Talk about bad decisions! So I'm not bashing, I'm afraid we are going up schits creek. I believe the product is solid, I also believe we are up against big pharma who have a lot to loose in antibiotic sales.. the have loads of money to protect their market. However that was a calculated risk on my part. Poor management was not in my calculated risk and I don't like it. A simple update and news release on Kym's part would have surely helped.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities